Baker Hughes
BKR
55.41
-1.72
-3.01%
Baker Hughes
US · BKR
#397 by market cap
Listed 1970
55.41
-1.72
-3.01%
Live - 5344 symbols - heartbeat 76s ago
· 2026-10-08 06:30
Pre-market
55.75
+0.61%
After-hours
55.40
-0.02%
Overnight
55.50
+0.16%
- Market cap
- 55.00B
- P/E (TTM)i
- 17.82
- P/Bi
- 2.76
- EPSi
- 2.60
- Div yieldi
- 1.66%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on BKR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.51, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.35% YoY
Margins
- Gross margin
- 23.60%
- Operating margin
- 12.83%
- Net margin
- 9.33%
Key ratios & quality
- Enterprise valuei
- 57.38B
- Altman Z-Scorei
- 2.51
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.88B | 23.84B | 20.71B | 20.50B | 21.16B | 25.51B | 27.83B | 27.73B |
| Gross profit | 3.99B | 4.43B | 3.20B | 4.05B | 4.40B | 5.90B | 6.48B | 6.54B |
| Selling & admin expenses | 2.70B | 2.83B | 2.40B | 2.47B | 2.51B | 2.61B | 2.46B | 2.39B |
| Research & development | -- | -- | -- | -- | -- | 651.00M | 643.00M | 600.00M |
| Operating profit | 1.29B | 1.60B | 795.00M | 1.58B | 1.89B | 2.64B | 3.38B | 3.56B |
| Pretax profit | 541.00M | 753.00M | -15.20B | 428.00M | 22.00M | 2.66B | 3.27B | 2.88B |
| Tax | 258.00M | 482.00M | 559.00M | 758.00M | 600.00M | 685.00M | 257.00M | 253.00M |
| Net profit | 283.00M | 271.00M | -15.76B | -330.00M | -578.00M | 1.97B | 3.01B | 2.62B |
| Basic EPS | 0 | 0 | -15 | 0 | -1 | 2 | 3 | 3 |
| Diluted EPS | 0.45 | 0.23 | -14.73 | -0.27 | -0.61 | 1.91 | 2.98 | 2.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 6.43B | 6.91B | 7.01B | 7.39B | 6.59B | 6.74B |
| Gross profit | 1.48B | 1.62B | 1.70B | 1.75B | 1.50B | 1.58B |
| Selling & admin expenses | 577.00M | 567.00M | 607.00M | 636.00M | 562.00M | 569.00M |
| Research & development | 146.00M | 161.00M | 146.00M | 147.00M | 133.00M | 143.00M |
| Operating profit | 752.00M | 887.00M | 948.00M | 970.00M | 809.00M | 865.00M |
| Pretax profit | 561.00M | 967.00M | 821.00M | 528.00M | 1.27B | 892.00M |
| Tax | 152.00M | 256.00M | 204.00M | -359.00M | 336.00M | 210.00M |
| Net profit | 409.00M | 711.00M | 617.00M | 887.00M | 938.00M | 682.00M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.40 | 0.71 | 0.61 | 0.88 | 0.93 | 0.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 14.97B | 15.22B | 16.46B | 15.07B | 14.59B | 16.30B | 17.21B | 18.83B |
| Cash & ST investments | 3.72B | 3.25B | 4.13B | 3.85B | 2.49B | 2.65B | 3.36B | 3.72B |
| Inventory | 4.62B | 4.61B | 4.42B | 3.98B | 4.59B | 5.09B | 4.95B | 4.95B |
| Total assets | 52.44B | 53.37B | 38.01B | 35.31B | 34.18B | 36.95B | 38.36B | 40.88B |
| Total current liabilities | 9.02B | 10.01B | 10.23B | 9.13B | 11.08B | 12.99B | 12.99B | 13.88B |
| Short-term debt | 942.00M | 321.00M | 889.00M | 40.00M | 678.00M | 148.00M | 53.00M | 689.00M |
| Long-term debt | 6.29B | 6.30B | 6.74B | 6.69B | 5.98B | 5.87B | 5.97B | 5.40B |
| Total liabilities | 17,426,000,000.00 | 18,870,000,000.00 | 19,765,000,000.00 | 18,562,000,000.00 | 19,656,000,000.00 | 21,426,000,000.00 | 21,308,000,000.00 | 21,871,000,000.00 |
| Total equity | 35.01B | 34.50B | 18.24B | 16.75B | 14.53B | 15.52B | 17.06B | 19.01B |
| Retained earnings | 25.00M | 0 | -9.94B | -10.16B | -10.76B | -8.82B | -5.84B | -3.25B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 16.84B | 17.62B | 17.53B | 18.83B | 28.59B | 30.58B |
| Cash & ST investments | 3.28B | 3.09B | 2.69B | 3.72B | 14.76B | 15.73B |
| Inventory | 5.16B | 5.11B | 5.04B | 4.95B | 4.87B | 4.96B |
| Total assets | 38.11B | 38.74B | 39.23B | 40.88B | 50.90B | 52.62B |
| Total current liabilities | 12.59B | 12.52B | 12.44B | 13.88B | 13.41B | 14.60B |
| Short-term debt | 55.00M | 66.00M | 68.00M | 689.00M | 753.00M | 774.00M |
| Long-term debt | 5.97B | 5.97B | 5.99B | 5.40B | 15.41B | 15.48B |
| Total liabilities | 20,904,000,000.00 | 20,872,000,000.00 | 20,905,000,000.00 | 21,871,000,000.00 | 31,406,000,000.00 | 32,536,000,000.00 |
| Total equity | 17.21B | 17.87B | 18.33B | 19.01B | 19.49B | 20.08B |
| Retained earnings | -5.44B | -4.74B | -4.13B | -3.25B | -2.32B | -1.64B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.76B | 2.13B | 1.30B | 2.37B | 1.89B | 3.06B | 3.33B | 3.81B |
| Depreciation & amortization | 1.49B | 1.42B | 1.32B | 1.11B | 1.06B | 1.09B | 1.14B | 1.19B |
| Free cash flow | 767.00M | 886.00M | 330.00M | 1.52B | 899.00M | 1.84B | 2.05B | 2.54B |
| Dividends paid | -810.00M | -745.00M | -744.00M | -749.00M | -726.00M | -786.00M | -836.00M | -910.00M |
| Stock buybacks / issuance | -2.49B | -250.00M | 0 | -434.00M | -828.00M | -538.00M | -484.00M | -384.00M |
| Ending cash balance | 3.72B | 3.25B | 4.13B | 3.85B | 2.49B | 2.65B | 3.36B | 3.72B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 709.00M | 510.00M | 929.00M | 1.66B | 500.00M | 1.35B |
| Depreciation & amortization | 285.00M | 294.00M | 282.00M | 327.00M | 354.00M | 333.00M |
| Free cash flow | 409.00M | 209.00M | 634.00M | 1.29B | 164.00M | 1.05B |
| Dividends paid | -229.00M | -227.00M | -227.00M | -227.00M | -228.00M | -228.00M |
| Stock buybacks / issuance | -188.00M | -196.00M | 0 | 0 | 0 | 0 |
| Ending cash balance | 3.28B | 3.09B | 2.69B | 3.72B | 14.76B | 15.73B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 1.21 | 0.65 | -57.09 | -1.58 | -4.11 | 13.06 | 18.47 | 14.49 |
| ROA %i | 0.36 | 0.24 | -21.76 | -0.60 | -1.73 | 5.46 | 7.91 | 6.53 |
| ROIC %i | 1.50 | 1.13 | -39.72 | 0.00 | -1.94 | 9.91 | 14.27 | 11.67 |
| 5-year avg ROE %i | -- | -- | -11.18 | -11.50 | -12.18 | -9.82 | -6.25 | 8.06 |
| EBIT margin %i | 3.34 | 4.15 | -72.15 | 3.55 | 1.30 | 11.26 | 12.44 | 11.17 |
| FCF / sales %i | 3.35 | 3.72 | 1.59 | 7.40 | 4.25 | 7.21 | 7.38 | 9.15 |
| Current ratioi | 1.66 | 1.52 | 1.61 | 1.65 | 1.32 | 1.25 | 1.32 | 1.36 |
| Quick ratioi | 1.07 | 0.97 | 0.95 | 1.04 | 0.76 | 0.75 | 0.81 | 0.75 |
| Debt / assetsi | 13.78 | 12.41 | 20.08 | 19.05 | 19.48 | 16.30 | 15.70 | 14.89 |
| LT debt / equityi | 35.99 | 28.73 | 52.31 | 45.09 | 41.55 | 38.22 | 35.34 | 28.66 |
| Interest coveragei | 3.43 | 4.18 | -56.58 | 2.43 | 1.09 | 13.29 | 17.49 | 13.96 |
| Revenue CAGR (3Y) %i | 11.09 | 22.14 | 6.42 | -3.59 | -3.90 | 7.20 | 10.72 | 9.44 |
| Net income CAGR (3Y) %i | -- | -20.42 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 4.61 | -- | -- | 25.55 | 0.49 | 77.26 | 10.61 | 41.31 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.04 | 18.32 | 16.83 | 14.49 | 17.14 | 16.47 |
| ROA %i | 7.78 | 8.09 | 7.53 | 6.53 | 7.00 | 6.78 |
| ROIC %i | 14.03 | 14.37 | 13.32 | 11.67 | 11.42 | 11.13 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.19 | 12.83 | 12.11 | 11.17 | 13.79 | 13.64 |
| FCF / sales %i | 7.23 | 7.84 | 7.54 | 9.15 | 8.22 | 11.28 |
| Current ratioi | 1.34 | 1.41 | 1.41 | 1.36 | 2.13 | 2.09 |
| Quick ratioi | 0.79 | 0.77 | 0.74 | 0.75 | 1.60 | 1.53 |
| Debt / assetsi | 15.81 | 15.58 | 15.44 | 14.89 | 31.76 | 30.89 |
| LT debt / equityi | 35.03 | 33.72 | 32.98 | 28.66 | 79.79 | 77.75 |
| Interest coveragei | 16.31 | 16.48 | 15.54 | 13.96 | 14.97 | 14.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Oilfield Services & Equipment (OFSE) is the largest reported line at 51.19% of revenue, across 2 reported segments.
- Industrial & Energy Technology (IET) follows at 48.81%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Oilfield Services & Equipment (OFSE)51.19%
Industrial & Energy Technology (IET)48.81%
Quote time 2026-10-08 06:30:18 · For reference only, not investment advice and not tailored to your situation.